MADISON,
WI - September 17, 2003 - NimbleGen Systems, Inc., producer of
custom high-density DNA microarrays using proprietary Maskless
Array Synthesis (MAS) technology, has named Dr. Stanley Rose as
President and Chief Executive Officer. Dr. Rose will also serve
as a member of the company's Board of Directors.
"My
career has been devoted to commercializing powerful technologies
for genome research," said Dr. Rose. "The market for
NimbleGen's custom array technology is as vast as the diversity
of biology itself. I'm excited by the opportunity to help scientists
gain access to NimbleGen's technology so they can advance their
research, regardless of what genome they are studying or what
DNA content they desire in an array."
Dr. Rose is a seasoned biotech entrepreneur. Highlights of his
15+ year career in the genomics research business include directing
the PCR business during its most dynamic growth phases for Perkin-Elmer
and Applied Biosystems and founding and growing Genetic MicroSystems,
a microarray products company that was sold to Affymetrix in 2000.
Dr. Rose currently serves as Chairman of the Board of OpGen, Inc.,
and as a Director of GenTel BioSurfaces, Inc., both Madison, WI,-based
biotech ventures. He received his B.A. from Cornell University
and his Ph.D. from the Massachusetts Institute of Technology.
"I'm
very proud of NimbleGen's success in creating a powerful, proprietary
technology that offers significant competitive advantages and
of our continued ability to attract great people to this Company,"
remarked NimbleGen's Chairman of the Board, Robert Palay. "We're
delighted to have Stan lead the Company through our next stage
of growth as we make NimbleGen's technology more widely available
to biologists who need high quality array analysis for their research."
About
NimbleGen Systems Inc.
NimbleGen Systems provides customized high-density microarray
products and services with unprecedented flexibility for functional
genomics experiments. NimbleGen's technology combines photo-deposition
chemistry with digital light projection to shorten array fabrication
from months to less than three hours, and NimbleGen scientists
are aggressively developing and deploying new microarray applications
to speed discovery research. Customers benefit from extreme flexibility,
optimized array design, highly reproducible array fabrication
and statistically robust results-all with low cost and quick turnaround.
